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Abstract
Background: The presentation of Kaposi sarcoma is divided into four known clinical subtypes. In this case report
we describe classic Kaposi sarcoma in an African-American heterosexual, diabetic, seronegative human
immunodeficiency virus male. Classic Kaposi sarcoma is rare in this patient demographic and can be easily
misdiagnosed.
Case presentation: The patient presented with a lesion between the fourth and fifth digits of his right foot which
was initially diagnosed as a diabetic foot ulcer. Despite local wound care, the lesion did not resolve. A shave biopsy
was performed and histopathology findings were consistent with classic Kaposi sarcoma.
Conclusions: The patient tolerated local radiotherapy well and had complete resolution of his pedal lesion. There
have been emerging associations between diabetes and Kaposi sarcoma. As such, clinicians should have a low
threshold when considering the biopsy of suspicious pedal lesions in patients with diabetes. The utilization of
appropriate biopsy technique may lead to the diagnosis of classic KS tumors in populations outside of the current
four widely accepted clinical subtypes.
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Background
Kaposi sarcoma (KS) is a vascular tumor caused by the
proliferation of spindle cells in the endothelium of blood
vessels [1]. In the United States there are four widely ac-
cepted distinct KS clinical subtypes. Classic KS, typically
benign and mostly limited to the hands and the feet, is
seen primarily in elderly men of Eastern European and
Mediterranean origin [2]. Endemic or African KS is most
commonly seen in indigenous Sub-Saharan Africans and
is independent of the human immunodeficiency virus
(HIV) [3]. Iatrogenic KS is associated with recipients of
organ transplants and patients undergoing immunosup-
pression therapy [4]. Epidemic or acquired immune defi-
ciency syndrome (AIDS) KS is the most common tumor
seen in people infected with HIV. This subtype is most
frequently described in HIV seropositive homosexual
and bisexual men [2, 5]. Each KS clinical subtype is
linked through infection of the Kaposi sarcoma-
associated herpes virus (KSHV), also known as human
herpesvirus 8 (HHV-8) [6]. We present a case describing
the unusual presentation of classic KS in a diabetic
African-American heterosexual HIV seronegative male.
Case presentation
An 80-year-old African-American male presented to the
University of Michigan Hospital and Health Systems
Comprehensive Wound Center for ongoing care of a
painful right foot fifth digit wound. He first noticed the
lesion after stubbing the digit 2 months prior. He pre-
sented to his primary care doctor 1 month after the in-
jury and the lesion was diagnosed as a diabetic foot
ulcer (DFU). The lesion improved minimally with local
wound care. Due to stagnation of the suspected DFU the
patient presented to the wound center for further care.
Upon initial wound center presentation, a granuloma-
tous mass was noted to the medial aspect of the right
fifth digit (Fig. 1). A biopsy of the lesion was
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subsequently scheduled. However, upon presenting to
the biopsy procedure, the patient stated the granuloma-
tous mass had sloughed off in his sock the week prior
leaving only a small partial-thickness ulcer (Fig. 2). The
patient elected to defer the biopsy as his symptoms had
improved. The patient continued regular monthly
follow-up at the wound center with development of his
wound into two painful papules.
The patient’s past medical history was significant for type
2 diabetes mellitus T2DM, hypertension, hyperlipidemia,
asthma, and dementia. He denied a family history of skin
lesions and cancer. He did not take any immunosuppressive
medication. The patient was a lifelong non-smoker and de-
nied alcohol and illicit drug use. He was married, hetero-
sexual and monogamous. At the time of presentation his
last recorded hemoglobin A1c was 6.1%. Clinical examin-
ation revealed palpable pedal pulses with triphasic flow to
the bilateral dorsalis pedis artery and posterior tibialis ar-
tery. His right hallux toe pressure was 126mmHg and his
left hallux toe pressure was 184mmHg. He had diminished
protective sensation, 2 out of 4 sites bilaterally, as tested
with 10-g 5.07 Semmes-Weinstein monofilament as per
American Diabetes Association guidelines [7]. To the med-
ial aspect of the patient’s right fifth digit were two firm,
cyanotic appearing papules. The distal papule measured
0.5 cm in diameter and the proximal papule measured 0.7
cm in diameter (Fig. 3). There were no clinical signs of in-
fection noted to the right foot. As the lesion caused moder-
ate discomfort and did not improve despite 2 months of
local care at the wound center, a biopsy of the lesion was
again recommended.
After obtaining written informed consent a #15 blade
was used to perform a shave biopsy of both the right
fifth digit proximal and distal papules. The two speci-
mens were labeled appropriately and sent separately to
the University of Michigan Hospital and Health Systems
pathology laboratory for assessment. The pathology re-
port identified the specimen obtained from the distal
papule as the superficial aspect of a hemorrhagic vascu-
lar lesion. The specimen from the proximal papule was
identified as Kaposi sarcoma, nodular stage, transected
at the deep margin. Hematoxylin and eosin stain demon-
strated dermal nodules with haphazard spindle cell pro-
liferation of endothelial cells forming vascular spaces
which is diagnostic of classic KS (Fig. 4). The tumor cells
showed diagnostic positive staining for HHV-8 (Fig. 5).
Fig. 1 Right foot medial fifth digit with granulomatous mass
Fig. 2 Right foot fifth digit partial thickness wound with sloughed
granulomatous mass Fig. 3 Right foot fifth digit with two distinct cyanotic papules
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After the resulting classic KS diagnosis, the patient
was referred to the Surgical Oncology Clinic at the Uni-
versity of Michigan Hospital and Health Systems. He
underwent a series of blood tests to assess for under-
lying immunosuppression including HIV testing and a
complete blood count with platelet and differential. He
was determined to be HIV seronegative without any
other clinical findings of immunosuppression. His case
was reviewed by the University of Michigan Sarcoma
Medical Oncology Department as well as the Multi-
disciplinary Sarcoma Tumor Board. The consensus of
the combined board was local therapy with radiation
without surgical intervention. The patient underwent
30 Gy of radiation in 10 fractions directed to the right
foot fifth digit. The patient tolerated radiotherapy well
and upon finishing his course of therapy, the KS le-
sion to the right foot had completely resolved. Upon
a 10 month follow-up from initiation of radiation, the
patient was disease free.
Discussion
KS is rare in the general population. The disease repre-
sents about 1% of all diagnosed cancers worldwide [8].
The case we present is unusual as the clinical character-
istics of the patient discussed do not fit those typical of
classic KS or any of the other KS subtypes seen in the
current literature. Classic KS is seen most commonly in
men (male to female ratio 10–15:1) of Mediterranean or
Eastern European origin. It is particularly seen in Ash-
kenazic Jews in their fifth through eighth decade of life
[1, 4]. As classic KS most often affects the feet, it is not
uncommon for KS lesions to be initially misdiagnosed as
diabetic foot ulcers [9–11]. There are notable differences
that can aid in distinguishing between DFUs and KS le-
sions. DFUs are typically divided into either neuropathic
ulcers or neuroischemic ulcers [12]. Neuropathic ulcers,
associated with diabetic peripheral neuropathy, are typic-
ally found on the weightbearing surfaces of a well-
perfused foot. Common wound locations include the
plantar metatarsal heads or the heel. Diabetic neuro-
pathic ulcers are typically painless with well-defined
wound margins. An important feature of neuropathic ul-
cers is peri-ulcer callus development. Callus formation is
the result of repetitive mechanical stress, usually pres-
sure and friction, in an insensate foot. If a callus is left
intact for a prolonged period of time, the tissue under-
lying the callus will ulcerate. Neuroischemic ulcers have
the underlying etiology of neuropathy and poor arterial
perfusion. The foot type is usually pulseless, cool to
touch, with atrophic skin and diminished pedal hair.
Neuroischemic wounds commonly appear on the mar-
gins of the foot such as the foot edge, distal aspects of
toes and back of the heel. The wounds can occur spon-
taneously or as a result of microtrauma [13]. Because of
ischemia, neuroischemic wounds can be quite painful. A
significant factor of DFUs is that once the underlying
etiology is controlled, i.e. pressure or ischemia, the
wound should improve or heal with local wound care.
Though the patient in our case study had peripheral
neuropathy, classic KS lesions can occur in diabetic pa-
tients independent of neuropathy or ischemia. The le-
sions are usually on the soles and arches of the foot [14].
Pedal interdigital presentation of KS lesions is possible
as well, which differs from the usual presentations of
DFUs. Also, in contrast to DFUs, it is unusual for a clas-
sic KS lesion to initially present as a ulcer, with calloused
tissue, or as a blister. KS lesions generally present as
painless, violaceous plaques and nodules [15]. The le-
sions can appear either isolated or in groups. Enlarge-
ment and ulceration of a KS lesion occurs over
prolonged periods of time [16]. Unlike DFUs, local
Fig. 4 Histopathology hematoxylin and eosin stain with
magnification 200X showing spindle cell proliferation and slit-like
vascular spaces
Fig. 5 Proliferated spindle cells demonstrate positive staining
(brown) of the antibody to HHV-8
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wound care and removal of the suspected etiology will
not result in resolution of the KS lesion as it is a tumor
of viral origin.
The case presented serves as an example of the neces-
sity to biopsy pedal lesions that do not respond to stand-
ard therapy. In addition to DFUs classic KS lesions can
mimic other conditions such as pyogenic granuloma,
melanoma, melanocytic nevi, arteriovenous malforma-
tions or severe stasis dermatitis [17]. The acronym
“ABCDE” (asymmetry, border, color, diameter, and eleva-
tion) has longed served as a diagnostic protocol for mel-
anoma. Additionally, ‘CUBED’ is an alternative acronym
that can be used to aid clinicians in the diagnosis of sus-
picious lesions, particularly on the foot. In the ‘CUBED’
acronym: ‘C’ represents color of lesion; ‘U’ for uncer-
tainty of diagnosis; ‘B’ describes bleeding lesions includ-
ing chronic granulation tissue; “E” for enlargement or
worsening of lesion despite local therapy; and ‘D’ de-
scribes delay in healing beyond 2 months [18]. If a pedal
lesion displays any two features of the ‘CUBED’ acronym
then biopsy is warranted.
In general patients with diabetes are more susceptible
to pathogen infection and tumor growth [19, 20]. Several
epidemiological studies describe a possible association
between HHV-8 infection and T2DM [21]. More specific
correlations have been described in recent literature. In-
fection with HHV-8 is needed for KS development.
However, primary infection alone may not be sufficient
for tumor development [6]. Once a patient is infected
with HHV-8, the virus is typically latent. Ye et al. dem-
onstrated that high blood glucose levels in patients with
diabetes can promote HHV-8 lytic gene expression and
replication leading to the development of classic KS
[22]. Furthermore, Chang et al. showed that high glucose
levels not only increase HHV-8 reactivation in latent
cells, but also enhances the susceptibly of various host
target cells to HHV-8 infection [23]. To date there is
limited evidence related to a possible cause and effect
nature of T2DM and HHV-8. More scientific investiga-
tions in this area can provide new understandings in dia-
betic complications and aid in risk stratifications.
The patient’s demographic designation is another in-
teresting component of this case. As stated previously,
classic KS is most commonly seen in elderly Mediterra-
nean men. In recent years KS in African-American
males has been linked to an HIV seropositive status [24].
African-American adults have a higher prevalence of
T2DM than Whites [25]. Given the correlations of
T2DM and KS, it may be possible that HIV seronegative
African-Americans are at a higher risk of KS than previ-
ously thought. Classic KS is generally considered not life
threatening [26]. Though, increased morbidity has been
documented in African-Americans, who tend to have
more diffuse tumors, lower cure rates, and decreased
survival rates [15]. This could be associated with delayed
diagnosis. Due to their violaceous hue, KS lesions can be
difficult to detect in patients of darker complexion.
Mora and Lee described seronegative HIV KS diagnosed
histologically in 19 African-Americans from 1948 to
1983 [27]. Over 50 % of patients had KS lesions, specific-
ally on the foot. Sixteen percent of patients had diabetes
and the mortality rate of patients in this series was 21%.
In the United States African Americans have the highest
death rate and shortest survival rate for most cancers of
any racial and ethnic group [28]. As such, clinicians
should have a high degree of suspicion for malignancy
for atypical skin lesions in this population.
The patient did report that his right fifth digit lesion
was precipitated by stubbing the digit. Interestingly,
pedal trauma induced KS has been discussed in the lit-
erature. Berkowitz et al. described a case in which a 48-
year-old HIV positive man developed KS of the right
hallux after dropping a piece of wood on the digit [29].
The authors attributed KS in this patient to Koebner
phenomenon. Koebner phenomenon, also known as
Koebner response, is the development of skin disease at
a site of cutaneous injury in patients that are vulnerable
to that disease. Though Koebner phenomenon is most
commonly associated with psoriasis, it is accepted that
KS can occasionally exhibit the response [30]. Even with-
out immunodeficiency, several conditions, including in-
fections, tumors and immune reactions, can locally
appear on areas of the body that have been immuno-
logically undermined by trauma [31].
In clinical practice punch biopsy is the most accepted
biopsy technique for definitive diagnosis of a classic KS.
Punch biopsy provides a full-thickness specimen, which
allows for adequate depth for proper diagnosis [32, 33].
In this case report, a shave biopsy was used. The ration-
ale for shave biopsy was the patient’s lesion was small
(less than 1.0 cm) and relatively flat. Though in the case
presented defining classic KS histologic characteristics
were seen utilizing a shave biopsy technique, it must be
stressed that superficial shave biopsies can certainly miss
important diagnostic features located in deeper tissues.
More extensive biopsy techniques include excisional, in-
cisional and core needle. An excisional biopsy is an opera-
tive procedure that removes the entire lesion. Incisional
biopsies remove only part of the lesion for diagnostic sam-
pling and core needle involves using a fine needle to ob-
tain cells and tissue from the lesion [34].
Treatment for KS depends on the type and number of
lesions, the extent of the disease, as well as the overall
patient health. [34]. There is no definitive cure for KS
[35]. Radiation is now widely used and has been proven
effective in treating patients with symptomatic local dis-
ease [1, 36]. Due to the local and symptomatic nature of
the patient’s disease and his history of diabetes, our
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institutional Medical Oncology Department and Multi-
disciplinary Sarcoma Tumor Board recommended local
therapy. In regards to radiation therapy there is no uni-
versally accepted dose and fractionation [35]. A higher
cumulative dose tends to have better results than lower
doses [36]. The patient presented was treated with 30 Gy
of radiation in 10 fractions and had resolution of his
disease. Alternative local disease treatment includes
cryotherapy, topical retinoid treatment, curettage and
electrodessication, photodynamic therapy and intrale-
sional chemotherapy [34]. Patients with extensive disease
or recurrent KS can be managed with a combination of
surgery, radiation and chemotherapy [37].
Conclusion
This case is atypical as it shows classic KS in a hetero-
sexual, HIV-seronegative African-American male.
Though KS is common in indigenous Africans, classic
KS has been described as rare in the American black
heterosexual and HIV-seronegative population. Growing
literature suggests an association between diabetes and
KS, though the specifics of the association are unclear.
Given the current perceived rareness of KS in some pop-
ulations, the clinician should be astute when examining
suspicious pedal lesions in patients with diabetes to
avoid misdiagnoses and delayed treatment.
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